Gestodene

This classification denotes a therapeutic progestin with the molecular formula C21H26O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1664P6E6MI, chemically known as 18,19-dinorpregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)- but generally known as gestodene, which bears US NIH Compound Identifier 43249. European Medicines Agency schedules Gestodene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07901MIG. The term GESTODENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). GESTODENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gestodene under HS 29372300 and SITC 54153. As of Q4 2014, GESTODENE remains the US FDA Preferred Term for this commodity. Gestodene bears US NLM identifiers UMLS ID C0061246 and NCI Concept Code C87240. SMILES: OC1(C2(C(C3C(CC2)C2C(=CC(=O)CC2)CC3)C=C1)CC)C#C.